Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan 4;155(1):150-154.
doi: 10.1093/ajcp/aqaa169.

Cotesting in Cervical Cancer Screening

Douglas P Malinowski  1 , Molly Broache  1 , Laurence Vaughan  1 , Jeff Andrews  1 , Devin Gary  1 , Harvey W Kaufman  2 , Damian P Alagia  2 , Zhen Chen  2 , Agnieszka Onisko  3 , R Marshall Austin  3
Affiliations
Comment

Cotesting in Cervical Cancer Screening

Douglas P Malinowski et al. Am J Clin Pathol. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kaufman HW, Alagia DP, Chen Z, et al. Contributions of liquid-based (Papanicolaou) cytology and human papillomavirus testing in cotesting for detection of cervical cancer and precancer in the United States. Am J Clin Pathol. Published online July 8, 2020. doi:10.1093/ajcp/aqaa074. - DOI - PMC - PubMed
    1. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24:102-131. - PMC - PubMed
    1. Katki HA, Kinney WK, Fetterman B, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12:663-672. - PMC - PubMed
    1. Schiffman M, Kinney WK, Cheung LC, et al. Relative performance of HPV and cytology components of cotesting in cervical screening. J Natl Cancer Inst. 2018;110:501-508. - PMC - PubMed
    1. Ronco G, Giorgi-Rossi P, Carozzi F, et al. New Technologies for Cervical Cancer Screening (NTCC) Working Group . Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11:249-257. - PubMed